0.7717
price down icon0.30%   -0.0023
after-market Handel nachbörslich: .77 -0.0017 -0.22%
loading
Schlusskurs vom Vortag:
$0.774
Offen:
$0.77
24-Stunden-Volumen:
3.85M
Relative Volume:
3.36
Marktkapitalisierung:
$73.97M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-0.5286
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
-2.97%
1M Leistung:
-17.83%
6M Leistung:
-58.95%
1J Leistung:
-79.20%
1-Tages-Spanne:
Value
$0.7301
$0.7982
1-Wochen-Bereich:
Value
$0.7301
$0.899
52-Wochen-Spanne:
Value
$0.66
$3.93

Caribou Biosciences Inc Stock (CRBU) Company Profile

Name
Firmenname
Caribou Biosciences Inc
Name
Telefon
510-982-6030
Name
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Name
Mitarbeiter
147
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CRBU's Discussions on Twitter

Vergleichen Sie CRBU mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRBU
Caribou Biosciences Inc
0.7717 73.97M 34.48M -102.07M -104.90M -1.46
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-03 Herabstufung Evercore ISI Outperform → In-line
2023-11-08 Eingeleitet Cantor Fitzgerald Neutral
2023-10-31 Eingeleitet Evercore ISI Outperform
2023-07-11 Eingeleitet Truist Buy
2022-02-18 Eingeleitet RBC Capital Mkts Outperform
2021-12-01 Eingeleitet Oppenheimer Outperform
2021-11-30 Eingeleitet H.C. Wainwright Buy
2021-11-15 Hochstufung Citigroup Neutral → Buy
2021-08-17 Eingeleitet BofA Securities Buy
2021-08-17 Eingeleitet Citigroup Neutral
2021-08-17 Eingeleitet SVB Leerink Outperform
Alle ansehen

Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten

pulisher
10:19 AM

H.C. Wainwright cuts Caribou Biosciences stock target to $3 - Investing.com

10:19 AM
pulisher
08:55 AM

Quarterly Snapshot: Quick and Current Ratios for Caribou Biosciences Inc (CRBU) - DWinneX

08:55 AM
pulisher
08:44 AM

Caribou Biosciences Inc (CRBU) Stock: A Year of Decreases and Increases - investchronicle.com

08:44 AM
pulisher
08:19 AM

Caribou Biosciences Inc (CRBU) receives an In-line rating from Evercore ISI - knoxdaily.com

08:19 AM
pulisher
04:11 AM

Russell Investments Group Ltd. Boosts Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

04:11 AM
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Caribou Biosciences (CRBU) Restructures, Focuses on Key Oncology Programs - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Caribou stock in focus after portfolio shakeup (CRBU:NASDAQ) - Seeking Alpha

Apr 25, 2025
pulisher
Apr 24, 2025

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Caribou Biosciences (CRBU) Shifts Focus to Oncology, Reduces Wor - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Caribou Biosciences Inc [CRBU] Shares Fall Approximately -78.12% Over the Year - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Caribou Biosciences extends cash runway, focuses on oncology - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Caribou Biosciences, Inc. Announces Strategic Pipeline Prioritization and Workforce Reductions to Extend Cash Runway into H2 2027 - Nasdaq

Apr 24, 2025
pulisher
Apr 24, 2025

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 ... - Enidnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

East Bay biotech to cut a third of its workforce, reset around two cancer programs - The Business Journals

Apr 24, 2025
pulisher
Apr 24, 2025

Caribou Biosciences Inc (CRBU) stock analysis: A simple moving average approach - uspostnews.com

Apr 24, 2025
pulisher
Apr 22, 2025

CRBU’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Apr 22, 2025
pulisher
Apr 21, 2025

Recent Insider Activity Suggests Potential Gains for Caribou Biosciences Inc (CRBU) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by JPMorgan Chase & Co. - Defense World

Apr 21, 2025
pulisher
Apr 21, 2025

Caribou Biosciences, Inc. (NASDAQ:CRBU) Stake Boosted by JPMorgan Chase & Co. - American Banking and Market News

Apr 21, 2025
pulisher
Apr 20, 2025

Brokerages Set Caribou Biosciences, Inc. (NASDAQ:CRBU) PT at $10.33 - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

Q1 Earnings Estimate for CRBU Issued By Leerink Partnrs - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

THE ROSEN LAW FIRM, P. A., Caribou Biosciences, Inc. - The Bradford Era

Apr 17, 2025
pulisher
Apr 14, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Grows Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Buys New Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Sells 111,100 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect - markets.businessinsider.com

Apr 10, 2025
pulisher
Apr 10, 2025

Caribou Biosciences Inc [CRBU] President and CEO makes an insider purchase of 20,000 shares worth 20400.0. - knoxdaily.com

Apr 10, 2025
pulisher
Apr 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out - markets.businessinsider.com

Apr 08, 2025
pulisher
Apr 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com

Apr 06, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Acquires 79,636 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Caribou Biosciences stock hits 52-week low at $0.71 - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

Caribou Biosciences stock hits 52-week low at $0.71 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 03, 2025
pulisher
Apr 01, 2025

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 01, 2025
pulisher
Mar 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect - markets.businessinsider.com

Mar 30, 2025
pulisher
Mar 29, 2025

Bank of New York Mellon Corp Has $358,000 Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Mar 29, 2025
pulisher
Mar 27, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com

Mar 27, 2025
pulisher
Mar 26, 2025

Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives $10.33 Consensus Target Price from Analysts - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Caribou Biosciences stock hits 52-week low at $0.95 By Investing.com - Investing.com Canada

Mar 25, 2025
pulisher
Mar 25, 2025

Caribou Biosciences stock hits 52-week low at $0.95 - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 25, 2025
pulisher
Mar 22, 2025

Caribou Biosciences’ (CRBU) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out - Markets Insider

Mar 20, 2025
pulisher
Mar 20, 2025

Caribou Biosciences’ SWOT analysis: CRISPR pioneer’s stock faces critical juncture - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Truist Removes Price Target on Caribou Biosciences, Keeps Buy Rating; Price Target Was $19 - Marketscreener.com

Mar 20, 2025
pulisher
Mar 19, 2025

US Bancorp DE Buys 26,467 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect - Markets Insider

Mar 18, 2025
pulisher
Mar 17, 2025

Caribou Biosciences CEO Rachel E. Haurwitz buys $20,400 in stock By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Caribou Biosciences CEO Rachel E. Haurwitz buys $20,400 in stock - Investing.com India

Mar 17, 2025

Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Kapitalisierung:     |  Volumen (24h):